Novartis Investigative Site

Cullman, Alabama 35058

Use our guide to learn which trials are right for you!

We've found
4 trials
at this facility
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cullman, AL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Cullman, AL
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Cullman, AL
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cullman, AL
Click here to add this to my saved trials